v3.25.4

Accrued expenses and other current liabilities | 9 Months Ended
--- | ---
Dec. 31, 2025
Accrued Liabilities and Other Liabilities [Abstract] |
Accrued expenses and other current liabilities | Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following:
| December 31, 2025 |  | March 31, 2025
Accrued research and development costs | $ | 24,111 |  |  | $ | 19,606 |
Accrued compensation and benefits costs | 14,443 |  |  | 20,080 |
Accrued professional fees | 569 |  |  | 161 |
Other | 1,242 |  |  | 6,069 |
Total accrued expenses and other current liabilities | $ | 40,365 |  |  | $ | 45,916 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration